Risk of death of patients with cancer presenting with severe symptoms of infection, with or without documented COVID-19: In reply to van Dam et al
Eur J Cancer
.
2020 Nov:139:68-69.
doi: 10.1016/j.ejca.2020.08.018.
Epub 2020 Sep 6.
Authors
Souad Assaad
1
,
Christine Fuhrmann
1
,
Virginie Avrillon
1
,
Isabelle Ray-Coquard
2
,
Jean-Yves Blay
3
Affiliations
1
Centre Leon Berard, Lyon, France.
2
Centre Leon Berard, Lyon, France; Universite de Lyon, Lyon, France; Unicancer, Paris, France.
3
Centre Leon Berard, Lyon, France; Universite de Lyon, Lyon, France; Unicancer, Paris, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.
PMID:
32977222
PMCID:
PMC7474920
DOI:
10.1016/j.ejca.2020.08.018
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Neoplasms*
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Severe acute respiratory syndrome-related coronavirus*